FDA warned China-based Wickimed over quality system failures in making sterile single-use electrodes, including unsterilized product labeled sterile.
What happened
FDA inspected Wickimed's Huizhou, China facility from September 6 to September 14, 2021 and found the company was not following the Quality System regulation (the FDA rule for how medical devices must be made). Investigators found no sterilization validation data, no design control records, and multiple pallets of finished devices labeled "Sterile" that had never been sterilized at the off-site ethylene oxide (EtO) sterilization facility. The company's written responses were mostly in a foreign language with limited English translation, so FDA could not fully assess them.
What FDA found
The company had no procedure to make sure it receives complaints from the US distributor selling its private-label devices, and no agreement requiring the distributor to pass complaints along.
21 CFR 820.198(a)The company could not provide validation data or records showing its sterilization process reliably works.
21 CFR 820.75(a)The company lacked proper design control procedures and could not produce design history file or 510(k) documents for the electrodes.
21 CFR 820.30(a)Finished devices that had not been sterilized were labeled "Sterile" on multiple pallets intended for the US market, with no procedure to mark them non-sterile.
21 CFR 820.86Controlled documents, including internal audit records and sterilization and sterility test records, were found outside their designated locations.
21 CFR 820.40The company's adverse-event procedure was not written as a Medical Device Reporting procedure meeting FDA's reporting requirements.
21 CFR 803.17
What FDA wants
FDA asks the company to reply in writing within 15 business days describing the specific corrections and corrective actions taken, how it will prevent repeat violations, a timetable for anything not yet finished, and full English translations of all documents. FDA also says the devices will be held at the US border (detention without physical examination) until the violations are fixed.
Who should pay attention
- US brands and distributors that private-label these electrodes
- hospitals and clinics that buy sterile single-use electrodes
- contract manufacturers and sterilization providers serving US device firms
This is a summary. Read the original letter on fda.gov.